Operating Grant: TRANSCAN-4
Canadian Institutes of Health Research (CIHR)
The anticipated outcome of the funding opportunity is the development of innovative, personalized approaches for cancer diagnosis, patient stratification, and treatment, grounded in a deeper mechanistic understanding of metabolic alterations in cancer.
The maximum amount per grant is $450,000 for up to three years.
The preproposal is not required to be submitted to ORS prior to submission to TRANSCAN-4 Joint Call Secretariat.
Anticipated Notice of Decision: May 31, 2027
Funding Start Date: October 1, 2027
Deadlines
| UM Internal Deadline (to ADR) | Sponsor Deadline | |
|---|---|---|
Pre-Proposal Application |
| 21-Jul-2026 12:00 CEST |
Application | 14-Dec-2026 | 13-Jan-2027 12:00 CET |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.